Y8N-33869-56939
5 vaccinations
15 coded responses
61 check-ins
15 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 750 / TX
- Registered
- 2021-03-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
2TE-16784-42547
Child or adolescent in my care · Male · 2022-04-11
Timeline
-
2021-03-02
Registered in v-safe
-
2021-03-02
Dose 1 — Pfizer-BioNTech
-
2021-03-02
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Chills, Fatigue or tirednessAdult check-in
-
2021-03-03
Survey response — days 1–6 daily, dose 1MedDRA: Disturbance in attention, Feeling abnormal — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Feeling unfocused and "floatyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-04
Survey response — days 1–6 daily, dose 1MedDRA: Disturbance in attention, Irritability — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Unfocused and irritableMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-16
-
2021-03-23
Dose 2 — Pfizer-BioNTech
-
2021-03-23
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-24
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-25
Survey response — days 1–6 daily, dose 2MedDRA: Disturbance in attention, Dizziness, Hyperhidrosis, Irritability, Myoclonus — Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Periods of profuse sweating, difficulty focusing, irritability, dizzy, body jolt sensationsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Survey response — days 1–6 daily, dose 2MedDRA: Disturbance in attention, Hyperhidrosis, Irritability — Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Still some sweating, still a little hard to focus, irritableMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Joint pains, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-29
Survey response — days 1–6 daily, dose 2MedDRA: Insomnia, Vision blurred — Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Insomnia, difficulty focusingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-30
-
2021-04-06
Survey response — day 14, dose 2MedDRA: Insomnia — Feeling: GoodFree text: InsomniaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-13
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-06-22
- 2021-09-21
-
2021-10-06
Dose 3 — Pfizer-BioNTech
-
2021-10-06
Survey response — day 0, dose 3MedDRA: Irritability — Feeling: Fair · Site: Pain · Chills, Joint pains, Fatigue or tirednessFree text: IrritableMedDRA releases: 2024-11 · check-in free text available
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-08
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness, Insomnia — Feeling: Fair · Site: Pain · Joint pains, Fatigue or tirednessFree text: Dizziness, insomniaMedDRA releases: 2024-11 · check-in free text available
-
2021-10-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-10
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-12
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-11
- 2021-11-17
- 2022-01-05
- 2022-04-06
-
2022-04-08
Dose 4 — Pfizer-BioNTech
-
2022-04-11
Survey response — days 1–6 daily, dose 4MedDRA: Decreased appetite, Oral herpes — Feeling: Fair · Fever · Fatigue or tirednessFree text: Loss of appetite, cold sores all over bottom lipMedDRA releases: 2024-11 · check-in free text available
-
2022-04-12
Survey response — days 1–6 daily, dose 4MedDRA: Oral herpes — Feeling: GoodFree text: Really bad cold sores. Probably one of the worst outbreaks I've had.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-13
Survey response — days 1–6 daily, dose 4MedDRA: Oral herpes — Feeling: GoodFree text: Cold soresMedDRA releases: 2024-11 · check-in free text available
-
2022-04-14
Survey response — days 1–6 daily, dose 4MedDRA: Oral herpes — Feeling: GoodFree text: Still have cold sores but they are healingMedDRA releases: 2024-11 · check-in free text available
- 2022-04-15
- 2022-04-22
- 2022-04-29
- 2022-05-06
- 2022-05-13
- 2022-05-21
- 2022-07-08
-
2022-09-09
Dose 5 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-10
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-09-11
Survey response — days 1–6 daily, dose 5MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: SweatingMedDRA releases: 2024-11 · check-in free text available
-
2022-09-12
Survey response — days 1–6 daily, dose 5MedDRA: Hyperhidrosis, Oral herpes — Feeling: Fair · Site: Pain · Fatigue or tiredness, DiarrheaFree text: Sweating, cold soresMedDRA releases: 2024-11 · check-in free text available
- 2022-09-16
- 2022-09-23
- 2022-09-30
- 2022-10-07
- 2022-10-14
- 2022-10-21
-
2022-12-09
Survey response — 3 months, dose 5MedDRA: Influenza — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: FluMedDRA releases: 2024-11 · check-in free text available
- 2023-03-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-02 | Pfizer-BioNTech | |
| 2 | 2021-03-23 | Pfizer-BioNTech | |
| 3 | 2021-10-06 | Pfizer-BioNTech | No |
| 4 | 2022-04-08 | Pfizer-BioNTech | No |
| 5 | 2022-09-09 | Pfizer-BioNTech | Flu |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Feeling unfocused and "floaty
Systemic reaction (other): Unfocused and irritable
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Periods of profuse sweating, difficulty focusing, irritability, dizzy, body jolt sensations
Systemic reaction (other): Still some sweating, still a little hard to focus, irritable
Systemic reaction (other): Insomnia, difficulty focusing
Release 7 — day 14, dose 2
Symptoms: Insomnia
Release 10 — day 0, dose 3
Systemic reaction (other): Irritable
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Dizziness, insomnia
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Loss of appetite, cold sores all over bottom lip
Systemic reaction (other): Really bad cold sores. Probably one of the worst outbreaks I've had.
Systemic reaction (other): Cold sores
Systemic reaction (other): Still have cold sores but they are healing
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Sweating
Systemic reaction (other): Sweating, cold sores
Release 12 — 3 months, dose 5
Symptoms: Flu
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza | · | · | ✓ |
| SD | Insomnia | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
| SRO | Disturbance in attention | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
| SRO | Irritability | ✓ | ✓ | ✓ |
| SRO | Myoclonus | ✓ | ✓ | ✓ |
| SRO | Oral herpes | · | · | ✓ |
| SRO | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release